` BAI (BenevolentAI SA) vs DAX Index Comparison - Alpha Spread

BAI
vs
D
DAX Index

Over the past 12 months, BAI has underperformed DAX Index, delivering a return of -85% compared to the DAX Index's +30% growth.

Stocks Performance
BAI vs DAX Index

Loading
BAI
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
BAI vs DAX Index

Loading
BAI
DAX Index
Difference
www.alphaspread.com

Performance By Year
BAI vs DAX Index

Loading
BAI
DAX Index
Add Stock

Competitors Performance
BenevolentAI SA vs Peers

DAX Index
BAI
LLY
JNJ
NOVO B
ROG
Add Stock

BenevolentAI SA
Glance View

Market Cap
11.6m EUR
Industry
Pharmaceuticals

BenevolentAI SA is a holding company that engages in the research and development and sale of AI-enabled drugs. The firm through the combined capabilities of its AI platform, scientific ability and wet-lab facilities deliver new drug candidates with a higher probability of clinical success than those developed using traditional methods. The company has an array of scientifically validated discoveries. The Company, through its BenevolentAI Platform, offers in-house pipeline of over 20 disease programs, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies, such as AstraZeneca, as well as other research and charitable institutions.

BAI Intrinsic Value
0.857 EUR
Undervaluation 91%
Intrinsic Value
Price
Back to Top